Vera Therapeutics, Inc.VERANASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+104.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+104.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.6x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$15.86M+5.6%
2024$15.02M+149.4%
2023$6.02M+225.9%
2022$1.85M+3.0%
2021$1.79M+133.5%
2020$-5.35M-5055.6%
2019$108000.00-